◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Towa Pharmaceutical Co., Ltd. (4553) EPS 2023–2026
DATA UPDATED 2026-08-11
Towa Pharmaceutical Co., Ltd. annual earnings per share (EPS) for fiscal 2026 was JPY 106.66, a decrease of 72.3% from JPY 385.71 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
4553 Annual EPS
| EPS (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| Diluted EPS | JPY 107M | JPY 386M | JPY 329M | JPY 45M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
4553 Quarterly EPS
| EPS (quarterly) | 2025-06-30 |
|---|
| Diluted EPS | JPY 51M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
More 4553 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow
All 4553 financial statements → Interactive 4553 charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.